|Last Price$209.76||Day Change (%)2.22%|
|Open Price$206.62||Day Change ($)4.56|
|Day Range205.75–210.44||52-Week Range145.12–213.33|
As of Wed 5/27/2015 3:37:00 PM | USD
Research and Markets: Global Next Generation Sequencing Market 2015-2019 with Illumina , Roche Diagnostics & Thermo Fischer Scientific Dominating
Research and Markets: 2015 Analysis of Molecular Diagnostic Instrumentation, and Strategic Profiles of Leading Suppliers
Illumina ILMN reported second-quarter results Tuesday that beat our expectations, and we plan to raise our fair value estimate by several dollars per share. Revenue totaled $84.5 million for the quarter, a 103% increase from the year-ago period, which prompted the firm to significantly raise its ...
Continued technology advancements and market expansion support Illumina's narrow moat.
Global SNP Genotyping and Analysis Market to Touch US$17.65 Billion by 2019: Transparency Market Research
Competitive advantages have improved for Mead Johnson, while De La Rue's moat was downgraded to narrow and POSCO was deemed a no-moat company.
Recent deals have been driven more by tax strategies than therapeutic synergies.
While a majority of our top fund managers are outperforming this year, five of them truly stand out from the rest given their ability to outperform the market over all time periods.
Ownership data provide a look at who else owns the company.
Get our sector-by-sector take on the bond market, plus our five best bond ideas.